Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Wasserman Scott M. — Kailera Therapeutics, Inc. insider: 2 transactions · InsiderLens

Home / Insiders / Wasserman Scott M.

Wasserman Scott M.

Chief Medical Officer at Kailera Therapeutics, Inc. · on record since Apr 16, 2026

Insider trading activity of Wasserman Scott M.

Transactions on record: 2; since Apr 20, 2026

Open-market buys: 0

Open-market sells: 0

Companies traded: 1; last filing Apr 20, 2026

Figures computed from official regulatory filings — methodology.

Companies where Wasserman Scott M. has traded

Kailera Therapeutics, Inc.2 tx · Apr 20, 2026

Track record of Wasserman Scott M.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Wasserman Scott M.

Co-insiders of Wasserman Scott M.

Akamine ScottKailera Therapeutics, Inc.
Bain Capital Fund XIV, L.P.Kailera Therapeutics, Inc.
BAIN CAPITAL INVESTORS LLCKailera Therapeutics, Inc.
Bain Capital Life Sciences Fund IV, L.P.Kailera Therapeutics, Inc.
Bain Capital Life Sciences Investors, LLCKailera Therapeutics, Inc.
Bain Capital Life Sciences IV General Partner, LLCKailera Therapeutics, Inc.
Bain Capital XIV General Partner, LLC

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Kailera Therapeutics, Inc.

BCLS Fund IV Investments GP, LLCKailera Therapeutics, Inc.

BCLS Fund IV Investments, L.P.Kailera Therapeutics, Inc.

BCPE Perseus Investor GP, LLCKailera Therapeutics, Inc.

BCPE Perseus Investor, LPKailera Therapeutics, Inc.

Burgess Paul D.Kailera Therapeutics, Inc.

CANADA PENSION PLAN INVESTMENT BOARDKailera Therapeutics, Inc.

Cloghessy PaulaKailera Therapeutics, Inc.

Clyburn FrankKailera Therapeutics, Inc.

Coleman Jamie BethKailera Therapeutics, Inc.

CPP Investment Board Private Holdings (4) Inc.Kailera Therapeutics, Inc.

Hite ChristopherKailera Therapeutics, Inc.

Jiangsu Hengrui Pharmaceuticals Co., Ltd.Kailera Therapeutics, Inc.

Kaplan Andrew T.Kailera Therapeutics, Inc.

Koppel AdamKailera Therapeutics, Inc.

Liu YutingKailera Therapeutics, Inc.

MACKAY MARTINKailera Therapeutics, Inc.

MILLIGAN JOHN FKailera Therapeutics, Inc.

Pagan Douglas W.Kailera Therapeutics, Inc.

Renaud Ronald C JRKailera Therapeutics, Inc.

RTW INVESTMENTS, LPKailera Therapeutics, Inc.

Stuart Partners, LLCKailera Therapeutics, Inc.

WONG RODERICKKailera Therapeutics, Inc.

Company	Filed	Type	Qty	Price	Value · USD	Src
Kailera Therapeutics, Inc.	Apr 20, 2026	AwardD	100,000	0.00 USD	$0	SEC
Kailera Therapeutics, Inc.	Apr 20, 2026	AwardD	100,000	0.00 USD	$0	SEC